Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
Journal of Clinical Medicine · 02.06.2024 · 13 (11) · 3281
DOI: 10.3390/jcm13113281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.06.2024. Verfasst von Luigi Asmundo und 20 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroendocrine neoplasms (NENs) are a diverse group of tumors with varying clinical behaviors. Their incidence has risen due to increased awareness, improved diagnostics, and aging populations. The 2019 World Health Organization classification emphasizes integrating radiology and histopathology to characterize NENs and create personalized treatment plans. Imaging methods like CT, MRI, and PET/CT are crucial for detection, staging, treatment planning, and monitoring, but each of them poses different interpretative challenges and none are immune to pitfalls. Treatment options include surgery, targeted therapies, and chemotherapy, based on the tumor type, stage, and patient-specific factors. This review aims to provide insights into the latest developments and challenges in NEN imaging, diagnosis, and management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy.
- Department of Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
- Department of Radiology, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.
- Department of Surgery, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
- Department of Surgery, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
- Department of Oncology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
ORCID-Profile: Luigi Asmundo, Francesco Rizzetto, Mark Anderson, Motaz Qadan, Valentina Ambrosini, Maria Picchio, Laura Evangelista, Konstantin Nikolaou, Stefano Fanti, Angelo Vanzulli, Onofrio Antonio Catalano
Zitieren
APA
Asmundo, L., Rizzetto, F., Blake, M., Anderson, M., Mojtahed, A., Bradley, W., Shenoy-Bhangle, A., Fernandez-Del Castillo, C., Qadan, M., Ferrone, C., Clark, J., Ambrosini, V., Picchio, M., Mapelli, P., Evangelista, L., Leithner, D., Nikolaou, K., Ursprung, S., Fanti, S., …, & Catalano, O. A. (2024). Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers. Journal of Clinical Medicine, 13(11), 3281. https://doi.org/10.3390/jcm13113281
Vancouver
Asmundo L, Rizzetto F, Blake M, Anderson M, Mojtahed A, Bradley W, et al. Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers. Journal of Clinical Medicine. 2024;13(11):3281. doi:10.3390/jcm13113281
BibTeX
@article{Asmundo2024,
author = {Asmundo, Luigi and Rizzetto, Francesco and Blake, Michael and Anderson, Mark and Mojtahed, Amirkasra and Bradley, William and Shenoy-Bhangle, Anuradha and Fernandez-Del Castillo, Carlos and Qadan, Motaz and Ferrone, Cristina and Clark, Jeffrey and Ambrosini, Valentina and Picchio, Maria and Mapelli, Paola and Evangelista, Laura and Leithner, Doris and Nikolaou, Konstantin and Ursprung, Stephan and Fanti, Stefano and Vanzulli, Angelo and Catalano, Onofrio Antonio},
title = {Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {11},
pages = {3281},
doi = {10.3390/jcm13113281}
}
EUVIMED